Many of these patients respond to immunosuppressive treatment and plasma exchange as described in GAD 65 and amphiphysin antibody-associated SPS opening up a wide field of antibody-mediated neuropsychiatric disorders. The gene discussed is AMPH; the disease is stiff-person syndrome.